Skip to content
Wenlo
Sign in
← Markets
Market open · Closes 4:00 PM ET

GILD Gilead Sciences Inc.

NASDAQ
$167.87−$2.81 (−1.65%)

As of 11:21:00 AM ET

Loading chart…

Open
$169.63
Previous close
$170.68
Day range
166.52 – 172.50
52-week range
116.88 – 175.65
Volume
102.9K
Avg volume (3M)
6.1M
Market cap
$211.8B
P/E (TTM)
17.87
EPS (TTM)
−$2.65
Beta
0.33
Dividend yield
1.90%
Next earnings
Feb 9, 2027(estimated from past report dates; not yet confirmed by the company)
Ex-dividend
Sep 15, 2026
Sector
Healthcare

About Gilead Sciences Inc.

Gilead Sciences Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious and life-threatening diseases. Its current business centers on virology, oncology, and inflammation, with a particularly strong position in HIV treatment and a broader portfolio that also addresses liver disease, respiratory conditions, cardiovascular disease, and cancer. Gilead Sciences Inc. markets established therapies and newer medicines aimed at unmet medical needs, supported by ongoing research and clinical programs across multiple therapeutic areas. The company also works with partnerships and access programs that help expand the reach of its medicines in global markets. Headquartered in Foster City, California, Gilead Sciences Inc. operates as an important healthcare innovator with products and services that serve patients, clinicians, and health systems worldwide.

GILD news and filings

Loading filings…

Filings from SEC EDGAR.